Treatment Characteristics and Inherent Prostatic Features Do Not Predict Patient Outcome after High-Energy Transurethral Thermotherapy: A Prospective Study of ProstaLund Feedback Treatment™

Abstract

According to our results, the intraprostatic temperature, the duration of intraprostatic temperatures in the therapeutic range, and the pattern of blood flow did not predict HE-TUMT outcome. Treatment duration, consumed energy, and the magnitude of tissue necrosis did not translate into clinical efficacy. Clinical parameters were important predictors of outcome in patients not in retention.

Nonablative minimally invasive thermal therapies in the treatment of symptomatic benign prostatic hyperplasia

“…Ferakis et al [30 ] investigated the treatment characteristics of the Prostalund device in relation to clinical efficacy parameters in 48 patients of which 28 had an indwelling catheter, but neither the intraprostatic temperatures, the duration of this temperature in the therapeutic range, the bloodflow pattern, nor the treatment duration or the magnitude of tissue necrosis matched the clinical response. In the nonretention group, however, it appeared that the combination of time, temperature and maintenance of intraprostatic temperatures for a longer time are indicators for a clinical response.…”